FDA Draft Guidance: Patient-Focused Drug Development

The Food and Drug Administration has issued a draft guidance regarding the collection of comprehensive and representative patient input as it applies to the drug development process. It represents another important step in recognizing the importance of making sure the patient voice is always heard.

Read the draft guidance.

by Jonathan D. Katz